Prediabetes Reversal in India: What the Evidence Shows

The ICMR-INDIAB national study estimated 101 million people in India have diabetes and 136 million have prediabetes — more people currently sit in the reversible window than have crossed out of it. Prediabetes has no symptoms; it is found on a blood test or not at all, which is why routine screening matters more than waiting to feel unwell.

Underneath prediabetes is usually insulin resistance — your cells respond poorly to insulin, so the pancreas compensates by producing more of it. Persistently high insulin promotes fat storage, particularly visceral fat, and that visceral fat itself worsens insulin resistance further — a self-reinforcing loop. Insulin resistance is estimated to affect 25–30% of Indian adults, and South Asians develop it at lower BMIs than other populations, largely because they carry more visceral and liver fat at a given weight.

Common signals worth investigating with a doctor: weight concentrated around the waist (above roughly 90 cm in men, 80 cm in women), heavy sleepiness after carbohydrate-heavy meals, dark velvety patches of skin on the neck or underarms (acanthosis nigricans), and irregular periods or a PCOS diagnosis, since insulin resistance underlies most PCOS cases.

A standard fasting glucose test alone can miss early insulin resistance, because the pancreas compensates and keeps glucose normal for years before it starts to rise. HbA1c (average blood sugar over roughly three months) and fasting glucose together give a fuller picture — see the table below for the standard diagnostic ranges.

Ask for these tests if you have a family history of diabetes, a rising waist measurement, PCOS, fatty liver, high blood pressure, or a history of gestational diabetes. Given that Indian metabolic risk starts at lower BMIs than global charts suggest, waiting until you look unwell is waiting too long.

Yes, for most people, and the evidence is unusually strong. The Diabetes Prevention Program found lifestyle intervention — modest weight loss plus increased physical activity — reduced progression to type 2 diabetes by 58%, outperforming metformin in the same trial. Three-year data on tirzepatide has also examined its effect on progression to type 2 diabetes in people with obesity and prediabetes, for those where medication is clinically appropriate.

The honest framing: reversal holds while the changes hold. Think of it as moving to a different long-term pattern of eating and movement rather than completing a fixed programme — the 58% figure came from people who sustained their changes.

Lifestyle change is the first-line, strongest-evidence approach at the prediabetes stage. Where a doctor judges medication appropriate — based on your BMI, glucose trend and overall risk — GLP-1 medication can also improve insulin sensitivity directly, not just suppress appetite. If you have already progressed to type 2 diabetes, see our dedicated guide on diabetes reversal and weight loss with GLP-1 in India for that specific stage. This page focuses on the earlier, typically fully reversible, prediabetes and insulin-resistance stage.

The common pattern is not “too much food” so much as too much refined carbohydrate with too little protein. A plate of white rice with a small portion of dal is a large glucose load with little to blunt it. Practical shifts that work in real Indian kitchens: raise the protein share at each meal (dal, paneer, egg, curd, fish, chicken), move some refined grain back to whole grain, eat vegetables before the carbohydrate portion, and walk for ten minutes after dinner. None of this requires abandoning Indian food — it requires rebalancing the plate.

Skeletal muscle clears most of the glucose you eat, which makes resistance training mechanistically central, not optional. WHO guidelines recommend 150–300 minutes of moderate activity weekly plus muscle-strengthening on two or more days. Building muscle also raises your resting metabolism, compounding the benefit over time.